IFF Completed Divestiture of Microbial Control Business
IFF (NYSE:IFF) has successfully completed the divestiture of its Microbial Control business unit to LANXESS. This strategic move is part of IFF's ongoing efforts to streamline its operations and focus on core areas of business, which include food, beverage, health, biosciences, and scent. The company aims to leverage science and creativity to create innovative solutions for a sustainable future.
- Successful divestiture of the Microbial Control business unit enhances focus on core business areas.
- Strategic move is aimed at streamlining operations.
- None.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.
© 2022 by
View source version on businesswire.com: https://www.businesswire.com/news/home/20220630005790/en/
Chief Investor Relations & Communications Officer
212.708.7164
Michael.DeVeau@iff.com
Source: IFF
FAQ
What recent divestiture did IFF announce?
How does IFF plan to streamline its operations?
What is the strategic focus of IFF after the divestiture?
